Not checked for notices yet.
Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
Zhi Peng, Tianshu Liu, Jia Wei and 32 more
Cancer Communications · 2021
Cited by papers we hold 2
- HER2-targeted therapies in cancer: a systematic review · 2024No notice
- Gastric cancer treatment: recent progress and future perspectives · 2023No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.